BLOOD-BASED BIOMARKER FOR CANCER
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Jun 9, 2015
filing date -
Dec 22, 2014
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
A blood-based biomarker for cancer includes a specific amino acid group of at least seven amino acids. The at least seven amino acids include histidine, isoleucine, leucine, methionine, tryptophan, valine, and tyrosine. The specific amino acid group may further include phenylalanine. The cancer is at least one kind of cancer selected from the group consisting of liver cancer, colon cancer, lung cancer, gall bladder cancer, lymph node metastatic cancer, gastric cancer, pancreas cancer, bile duct cancer, breast cancer, malignant mesothelioma, and T-cell leukemia/lymphoma.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully